The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Age over 18

• Untreated or ineffectively treated arterial hypertension

Exclusion Criteria:

• Cholestatic disorders and severe hepatic failure

• Allergy to telmisartan

• Pregnancy and lactation period